Literature DB >> 6430999

Evidence for restriction of the ability of complement to lyse homologous erythrocytes.

J J Houle, E M Hoffmann.   

Abstract

This research explored the possibility that a mechanism for the inhibition of C exists that is capable of restricting lysis of antibody-sensitized homologous E. The ability of C to lyse E from six species was compared by using a passive lysis system that employed E coated with B. abortus LPS and bovine antibodies specific for B. abortus. A system was developed that permitted comparisons of the hemolytic efficiencies of heterologous and homologous C target cell combinations. C from all of the species tested lysed heterologous E effectively, but homologous E were poorly lysed. Furthermore, a serum factor appeared to be involved with restriction of lysis of homologous E:LPS:Ab by heterologous C, and the restriction was specific for homologous E. Human E:LPS:Ab that were washed after incubation with CH were resistant to subsequent lysis by heterologous C. This restriction did not occur at 0 degrees C or in the absence of antibodies. Incubation of homologous C with EH:LPS:Ab resulted in consumption of C1, C2, C3, and C4, but not C5. The treated CH would lyse sheep EAC1423, but it would not lyse sheep EA, EACI, or EAC142. Late reacting C components (C5 through C9) were not detectable on EH:LPS:Ab after incubation with CH, but C4 and C3 were bound to the cells. Rat late-reacting C components (rat C-EDTA) were capable of detecting C3 convertase sites on EH:LPS:Ab that had been reacted with CH. However, homologous late-reacting components and guinea pig late-reacting components were unable to detect the C3 convertase sites.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6430999

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

Review 1.  Complement deficiency.

Authors:  K M O'Neil
Journal:  Clin Rev Allergy Immunol       Date:  2000-10       Impact factor: 8.667

2.  C8 binding protein bears I antigenic determinants.

Authors:  P Blaas-Mautner; S Filsinger; B Berger; D Roelcke; G M Hänsch
Journal:  Ann Hematol       Date:  1991 Feb-Mar       Impact factor: 3.673

3.  Bacterial lipoteichoic acid sensitizes host cells for destruction by autologous complement.

Authors:  D S Hummell; J A Winkelstein
Journal:  J Clin Invest       Date:  1986-05       Impact factor: 14.808

4.  Human and rodent decay-accelerating factors (CD55) are not species restricted in their complement-inhibiting activities.

Authors:  C L Harris; O B Spiller; B P Morgan
Journal:  Immunology       Date:  2000-08       Impact factor: 7.397

5.  The ability to sensitize host cells for destruction by autologous complement is a general property of lipoteichoic acid.

Authors:  B D Weinreb; G D Shockman; E H Beachey; A J Swift; J A Winkelstein
Journal:  Infect Immun       Date:  1986-11       Impact factor: 3.441

Review 6.  Subversion of complement by hematophagous parasites.

Authors:  Hélène Schroeder; Patrick J Skelly; Peter F Zipfel; Bertrand Losson; Alain Vanderplasschen
Journal:  Dev Comp Immunol       Date:  2009       Impact factor: 3.636

7.  Resistance of cytolytic lymphocytes to perforin-mediated killing. Lack of correlation with complement-associated homologous species restriction.

Authors:  S B Jiang; P M Persechini; A Zychlinsky; C C Liu; B Perussia; J D Young
Journal:  J Exp Med       Date:  1988-12-01       Impact factor: 14.307

8.  Human monoclonal IgG isotypes differ in complement activating function at the level of C4 as well as C1q.

Authors:  C I Bindon; G Hale; M Brüggemann; H Waldmann
Journal:  J Exp Med       Date:  1988-07-01       Impact factor: 14.307

9.  Intracellular sensing of complement C3 activates cell autonomous immunity.

Authors:  Jerry C H Tam; Susanna R Bidgood; William A McEwan; Leo C James
Journal:  Science       Date:  2014-09-04       Impact factor: 47.728

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.